KIMBERLY REESE: Open Payments
NPI 1295444099 · MASON CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 10 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $284 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Neos Therapeutics, LP | 1 | $22 |
| Alkermes, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: FANAPT, Adzenys XR-ODT, ARISTADA, SPRAVATO, COBENFY, Jornay PM, REXULTI, VRAYLAR.
Industry payments across IA — which companies pay providers there.
